ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 1,945 | 1,954 | 1,904 | 1,904 | -51 | -2.6% | 94,800 |
| 2022/03/30 | 1,974 | 1,984 | 1,935 | 1,955 | -21 | -1.1% | 110,100 |
| 2022/03/29 | 1,981 | 1,984 | 1,964 | 1,976 | ±0 | ±0% | 134,400 |
| 2022/03/28 | 1,970 | 1,980 | 1,961 | 1,976 | ±0 | ±0% | 101,200 |
| 2022/03/25 | 1,993 | 1,995 | 1,966 | 1,976 | -4 | -0.2% | 85,900 |
| 2022/03/24 | 1,980 | 2,009 | 1,960 | 1,980 | -8 | -0.4% | 96,100 |
| 2022/03/23 | 1,941 | 1,988 | 1,938 | 1,988 | +54 | +2.8% | 75,200 |
| 2022/03/22 | 1,965 | 1,968 | 1,924 | 1,934 | -15 | -0.8% | 116,100 |
| 2022/03/18 | 1,971 | 1,971 | 1,912 | 1,949 | -12 | -0.6% | 272,000 |
| 2022/03/17 | 1,971 | 1,974 | 1,942 | 1,961 | +17 | +0.9% | 145,500 |
| 2022/03/16 | 1,977 | 1,986 | 1,943 | 1,944 | -22 | -1.1% | 140,400 |
| 2022/03/15 | 1,994 | 1,994 | 1,962 | 1,966 | -28 | -1.4% | 120,000 |
| 2022/03/14 | 2,003 | 2,013 | 1,994 | 1,994 | -5 | -0.3% | 83,900 |
| 2022/03/11 | 1,990 | 2,004 | 1,979 | 1,999 | -14 | -0.7% | 74,100 |
| 2022/03/10 | 1,964 | 2,014 | 1,959 | 2,013 | +78 | +4% | 99,200 |
| 2022/03/09 | 1,935 | 1,943 | 1,920 | 1,935 | ±0 | ±0% | 67,100 |
| 2022/03/08 | 1,918 | 1,951 | 1,909 | 1,935 | +6 | +0.3% | 88,300 |
| 2022/03/07 | 1,967 | 1,967 | 1,922 | 1,929 | -49 | -2.5% | 95,000 |
| 2022/03/04 | 1,980 | 1,997 | 1,972 | 1,978 | -11 | -0.6% | 63,600 |
| 2022/03/03 | 1,975 | 2,003 | 1,975 | 1,989 | +54 | +2.8% | 85,600 |
| 2022/03/02 | 1,964 | 1,965 | 1,935 | 1,935 | -43 | -2.2% | 69,600 |
| 2022/03/01 | 1,983 | 2,000 | 1,968 | 1,978 | -5 | -0.3% | 98,700 |
| 2022/02/28 | 1,980 | 1,996 | 1,962 | 1,983 | +3 | +0.2% | 78,000 |
| 2022/02/25 | 1,963 | 1,980 | 1,950 | 1,980 | +20 | +1% | 58,000 |
| 2022/02/24 | 1,938 | 1,960 | 1,934 | 1,960 | +22 | +1.1% | 33,900 |
| 2022/02/22 | 1,949 | 1,949 | 1,925 | 1,938 | -20 | -1% | 39,700 |
| 2022/02/21 | 1,960 | 1,964 | 1,947 | 1,958 | -18 | -0.9% | 35,500 |
| 2022/02/18 | 1,970 | 1,980 | 1,961 | 1,976 | -6 | -0.3% | 32,700 |
| 2022/02/17 | 1,996 | 2,002 | 1,975 | 1,982 | -12 | -0.6% | 53,400 |
| 2022/02/16 | 1,963 | 2,002 | 1,962 | 1,994 | +49 | +2.5% | 67,700 |
| 2022/02/15 | 1,945 | 1,958 | 1,935 | 1,945 | +6 | +0.3% | 51,700 |
| 2022/02/14 | 1,966 | 1,970 | 1,934 | 1,939 | -27 | -1.4% | 82,100 |
| 2022/02/10 | 1,953 | 1,966 | 1,944 | 1,966 | +18 | +0.9% | 49,200 |
| 2022/02/09 | 1,931 | 1,956 | 1,917 | 1,948 | +17 | +0.9% | 72,500 |
| 2022/02/08 | 1,919 | 1,935 | 1,912 | 1,931 | +23 | +1.2% | 52,500 |
| 2022/02/07 | 1,906 | 1,937 | 1,905 | 1,908 | -9 | -0.5% | 100,000 |
| 2022/02/04 | 1,925 | 1,925 | 1,900 | 1,917 | -15 | -0.8% | 73,500 |
| 2022/02/03 | 1,929 | 1,957 | 1,925 | 1,932 | -7 | -0.4% | 81,200 |
| 2022/02/02 | 1,902 | 1,946 | 1,902 | 1,939 | +37 | +1.9% | 78,100 |
| 2022/02/01 | 1,911 | 1,940 | 1,896 | 1,902 | -13 | -0.7% | 30,700 |
| 2022/01/31 | 1,885 | 1,915 | 1,874 | 1,915 | +30 | +1.6% | 36,900 |
| 2022/01/28 | 1,889 | 1,901 | 1,872 | 1,885 | +47 | +2.6% | 52,900 |
| 2022/01/27 | 1,912 | 1,917 | 1,837 | 1,838 | -97 | -5% | 105,800 |
| 2022/01/26 | 1,931 | 1,945 | 1,920 | 1,935 | -1 | -0.1% | 48,600 |
| 2022/01/25 | 1,974 | 1,974 | 1,919 | 1,936 | -18 | -0.9% | 54,800 |
| 2022/01/24 | 1,936 | 1,960 | 1,924 | 1,954 | -10 | -0.5% | 51,600 |
| 2022/01/21 | 1,958 | 1,968 | 1,947 | 1,964 | -2 | -0.1% | 65,700 |
| 2022/01/20 | 1,960 | 2,000 | 1,960 | 1,966 | +12 | +0.6% | 63,600 |
| 2022/01/19 | 1,998 | 1,998 | 1,954 | 1,954 | -44 | -2.2% | 73,300 |
| 2022/01/18 | 2,005 | 2,013 | 1,993 | 1,998 | -4 | -0.2% | 44,600 |
651～
700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
